Orchestra BioMed Holdings, Inc.
OBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | -4.4% | -21.9% | 551.8% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 92.3% | 93.3% | 90.9% | 125.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,425.8% | -1,855.8% | -918.1% | 2,764.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,313.3% | -1,779.7% | -951.3% | 2,943% |
| EPS Diluted | -1.66 | -1.48 | -1.32 | -0.019 |
| % Growth | -12.2% | -12.1% | -7,035.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |